Drug Testing Locations - Purdue University, IN

Drug Testing in Purdue University, IN

Purdue University, Indiana Statistics

In West Lafayette, Tippecanoe County, Purdue University reports that prescription drug misuse among students is higher than the national college average.

A survey in Tippecanoe County indicated that 20% of Purdue students have used illicit drugs in the past year.

Tippecanoe County law enforcement reported an increase in drug-related arrests around Purdue University in 2022.

The Purdue University Student Health Center noted a 10% rise in students seeking help for drug-related issues over two years in Tippecanoe County.

Alcohol use is prevalent among students, with approximately 60% admitting to binge drinking in West Lafayette, Tippecanoe County.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in Purdue University, IN & Drug Testing Policies

Employers in West Lafayette, Tippecanoe County, are adopting rigorous drug testing policies to ensure a safe work environment. Companies like Drug-Free Workplace promote compliance with state guidelines and prioritize employee health.

Workplaces often incorporate random or pre-employment drug testing, aligning with standards set by the Indiana Department of Workforce Development. These measures deter substance abuse and enhance productivity and safety in the local job market.

Government Efforts with Drug Problems in Purdue University, IN

The government has bolstered efforts to combat drug issues in West Lafayette, Tippecanoe County. Partners like the Indiana Family and Social Services Administration have rolled out prevention programs and treatment resources accessible to students at Purdue University.

Coordination with law enforcement agencies such as the Tippecanoe County Sheriff's Department aims to reduce drug-related incidents on campus. The state funds educational campaigns on drug risks and supports recovery initiatives for impacted individuals.

Local Drug Busts & News in Purdue University, IN

In recent years, Purdue University has seen a mix of drug-related events that have attracted attention from law enforcement. One significant event was a coordinated drug bust involving local police and campus security. The operation targeted a group suspected of distributing controlled substances within campus grounds, leading to several arrests and confiscation of illegal drugs and paraphernalia.

Students and faculty have raised concerns about the prevalence of drugs on campus. In response, Purdue University has implemented various educational programs and support services aimed at drug prevention and awareness. The university's efforts focus on promoting a safer, drug-free environment through collaboration with local law enforcement and community organizations.

Despite these efforts, challenges remain in battling drug misuse and abuse among students. Reports indicate that some students continue to struggle with substance abuse issues, which has prompted Purdue to expand their counseling and rehabilitation services. Increased patrolling by the campus police has also been initiated to curb the illegal drug activity and ensure a secure campus for all students and staff.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in Purdue University, IN. Trusted by employers nationwide for accurate results and exceptional service.

Indiana DOT/Non DOT Physicals

Indiana Vision Tests

Indiana Audiograms

Indiana Respirator Fit Tests

Indiana Lift Tests

Indiana Background Checks

Clinical Testing Services

TB Testing in IN

Diabetes Testing in IN

Infectious Disease Testing in IN

Sickle Cell Anemia Testing in IN

Women/Men's Health Testing in IN

Resources & Citations

Indiana Bitter Pill

Next Level Recovery Indiana

Butler University CDemC

Healthy Minds Healthy Neighborhoods

Indiana Prevention Resource Center

NCADD Indiana

YWCA Greater Lafayette

Purdue University Wellness Institute

Drug Testing Near Purdue University, IN

Odell, IN

Stockwell, IN

Brookston, IN

Otterbein, IN

Buck Creek, IN

Westpoint, IN

Dayton, IN

Crane, IN

Montmorenci, IN

Battle Ground, IN

Shadeland, IN

Lafayette, IN

West Lafayette, IN

Frequently Asked Questions

Customer Reviews